A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease

Journal of the National Medical Association

Volumn 101, Issue 10, 2009, Pages 1022-1033

  Haywood Jr , Carlton ^a,b   Beach, Mary Catherine ^a,b   Lanzkron, Sophie ^b   Strouse, John J ^b   Wilson, Renee ^b   Park, Haeseong ^c   Witkop, Catherine ^d   Bass, Eric B ^b   Segal, Jodi B ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d Preventive Medicine and Obstetrics/Gynecology   (United States)

Author keywords

Health care; Patient physician relationship; Sickle cell anemia; Treatment

Indexed keywords

HYDROXYUREA; PETHIDINE;

AMBULATORY CARE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; IRON CHELATION; MEDICAL EDUCATION; MEDICAL STAFF; PAIN; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; SELF CARE; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW;

ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; ATTITUDE OF HEALTH PERSONNEL; DISEASE PROGRESSION; DRUG UTILIZATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PAIN; PHYSICIAN'S PRACTICE PATTERNS;

EID: 70350630223     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)31069-5     Document Type: Article

References (68)

1. World Health Organization: The 59th World Health Assembly. Sickle-cell anaemia. WHA.59.20.2006.
2. Weatherall D, Akinyanju O, Fucharoen S. Inherited Disorders of Hemoglobin. In: Disease Control Priorities in Developing Countries. New York: Oxford University Press. 2006;663-680.
3. Platt OS, Brambilla DJ, Rosse WF et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-1644. (Pubitemid 124005049)
4. US Preventive Services Task Force. Screening for Hemoglobinopathies US Preventive Services Task Force, Guidelines from Guide to Clinical Preventive Services. 2nd ed. Williams and Wilkens; 1996.
5. McClish DK, Penberthy LT, Bovbjerg VE et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005;3:50.
6. Shapiro BS, Benjamin LJ, Payne R, Heidrich G. Sickle cell-related pain: perceptions of medical practitioners. J Pain Symptom Manage. 1997;14:168-174. (Pubitemid 27377600)
7. Department of Health and Human Services: National Heart, Lung, and Blood Institute. People Science Health. 2008.
8. Smith WR, Bovbjerg VE, Penberthy LT et al. Understanding pain and improving management of sickle cell disease: the PiSCES study. J Natl Med Assoc. 2005;97(2):183-193. (Pubitemid 40204537)
9. Davis H, Gergen PJ, Moore RM Jr. Geographic differences in mortality of young children with sickle cell disease in the United States. Public Health Rep. 1997;112(1):52-58. (Pubitemid 27053115)
10. Sox CM, Cooper WO, Koepsell TD, DiGiuseppe DL, Christakis DA. Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. JAMA. 2003;290(8):1057-1061.
11. Lanzkron S, Haywood C Jr, Segal JB, and Dover GJ. Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. Am J Hematol. 2006;81 (12):927-932. (Pubitemid 44864450)
12. Segal JB, Strouse JJ, Beach MC et al. Hydroxyurea for the Treatment of Sickle Cell Disease. Evid Rep Technol Assess (Summ). (in press)
13. Berlin JA. Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group. Lancet. 1997;350(9072):185-186.
14. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
15. Lincoln TM, Reif W. How much do sample characteristics affect the effect size? An investigation of studies testing the treatment effects for social phobia. J Anxiety Disord. 2004;18(4).
16. Tobin GA and Begley CM. Methodological rigour within a qualitative framework. J Adv Nurs. 2004;48(4):388-396.
17. Horsburgh D. Evaluation of qualitative research. J Clin Nurs. 2003;12(2):307-312.
18. Ratanawongsa N, Thomas PA, Marinopoulos SS et al. Reliability of Methods for Evaluating Continuing Medical Education: A Systematic Review. Acad Med. In press.
19. Atkins D, Best D, Briss PA et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490.
20. Methods Reference Manual for Comparative Effectiveness Reviews. 2007;1-127.
21. Hankins J, Hinds P, Day S et al. Therapy preference and decision-making among patients with severe sickle cell anemia and their families&.. Pediatr Blood Cancer. 2007;48(7):705-710. (Pubitemid 46717619)
22. Treadwell MJ, Law AW, Sung J et al. Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatr Blood Cancer 2005;44(5):500-507. (Pubitemid 40614499)
23. Wurst KE and Sleath BL. Physician knowledge and adherence to prescribing antibiotic prophylaxis for sickle cell disease. Int J Qual Health Care. 2004;16(3):245-251.
24. Elliott V, Morgan S, Day S, Mollerup LS, and Wang W. Parental health beliefs and compliance with prophylactic penicillin administration in children with sickle cell disease. J Pediatr Hematol Oncol. 2001;23(2):112-116. (Pubitemid 32162673)
25. Teach SJ, Lillis KA, and Grossi M. Compliance with penicillin prophylaxis in patients with sickle cell disease. Arch Pediatr Adolesc Med. 1998;152(3):274-278. (Pubitemid 28124516)
26. Jensen SA, Elkin DT, Hilker K, Jordan S, Iyer R, and Smith MG. Caregiver knowledge and adherence in children with sickle cell disease: Knowing is not doing. J. Clin Psychol Med Settings. 2005;12(4):333-337. (Pubitemid 41662403)
27. Armstrong FD, Pegelow CH, Gonzalez JC, and Martinez A. Impact of children's sickle cell history on nurse and physician ratings of pain and medication decisions. J Pediatr Psychol. 1992;17(5):651-664.
28. Pence L, Valrie CR, Gil KM, Redding-Lallinger R, and Daeschner C. Optimism Predicting Daily Pain Medication Use in Adolescents with Sickle Cell Disease. J. Pain Symptom Manage. 2007;33(3):302-309. (Pubitemid 46357595)
29. Telfair J, Haque A, Etienne M, Tang S, Strasser S. Rural/urban differences in access to and utilization of services among people in Alabama with sickle cell disease. Public Health Rep. 2003;118(1):27-36. (Pubitemid 36262460)
30. Logan DE, Radcliffe J, and Smith-Whitley K. Parent factors and adolescent sickle cell disease: associations with patterns of health service use. J Pediatr Psychol. 2002;27(5):475-484. (Pubitemid 34747204)
31. Wojciechowski EA, Hurtig A, and Dorn L. A natural history study of adolescents and young adults with sickle cell disease as they transfer to adult care: a need for case management services. J Pediatr Nurs. 2002;17(1):18-27. (Pubitemid 40439259)
32. Haque A and Telfair J. Socioeconomic distress and health status: the urban-rural dichotomy of services utilization for people with sickle cell disorder in North Carolina. J Rural Health. 2000;16(1):43-55. (Pubitemid 30484366)
33. Barakat LP, Smith-Whitley K, and Ohene-Frempong K. Treatment adherence in children with sickle cell disease: Disease-related risk and psychosocial resistance factors. J. Clin. Psychol. Med. Settings. 2002;9(3):201-209.
34. Belgrave FZ and Lewis DM. The role of social support in compliance and other health behaviors for African Americans with chronic illnesses. J Health Soc Policy. 1994;5(3-4):55-68.
35. Zumberg MS, Reddy S, Boyette RL, Schwartz RJ, Konrad TR, and Lottenberg R. Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists. Am J Hematol. 2005;79(2):107-113. (Pubitemid 40770668)
36. Pack-Mabien A, Labbe E, Herbert D, and Haynes J Jr. Nurses' attitudes and practices in sickle cell pain management. Appl Nurs Res. 2001;14(4):187-192. (Pubitemid 33601944)
37. Murray N and May A. Painful crises in sickle cell disease-patients' perspectives. BMJ. 1988;297(6646):452-454. (Pubitemid 18190005)
38. Telfair J, Myers J, and Drezner S. Does race influence the provision of care to persons with sickle cell disease? Perceptions of multidisciplinary providers. J Health Care Poor Underserved. 1998;9(2):184-195. (Pubitemid 128456869)
39. Vichinsky E, Rust D, and Lubin B. A possible disparity between standard of care and delivery of care in sickle cell disease, as assessed from sickle cell centers. Int J Pediatr. Hematol Oncol. 1999;6(3):189-197. (Pubitemid 29363872)
40. Walters MC, Patience M, Leisenring W et al. Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 1996;2(2):100-104. (Pubitemid 126488201)
41. Booker MJ, Blethyn KL, Wright CJ, and Greenfield SM. Pain management in sickle cell disease. Chronic Illn. 2006;2(1):39-50. (Pubitemid 44146065)
42. Rouse CM. Paradigms and politics: shaping health care access for sickle cell patients through the discursive regimes of biomedicine. Cult Med Psychiatry. 2004;28(3):369-399.
43. Maxwell K, Streetly A, and Bevan D. Experiences of hospital care and treatment seeking for pain from sickle cell disease: qualitative study. BMJ. 1999;318(7198):1585-1590. (Pubitemid 29267771)
44. Tucker C, Spencer J, Dowling PT, and Allman L. Developing a community for patients with sickle cell anemia at Harbor-UCLA. Emphasis Nurs. 1995;5(1):19-27.
45. Alleyne J and Thomas VJ. The management of sickle cell crisis pain as experienced by patients and their carers. J Adv Nurs 1994;19(4)725-732.
46. Shelley B, Kramer KD, and Nash KB. Sickle cell mutual assistance groups and the health services delivery system. J Health Soc Policy. 1994;5(3-4):243-259. (Pubitemid 24363198)
47. Strickland OL, Jackson G, Gilead M, McGuire DB, and Quartes S. Use of focus groups for pain and quality of life assessment in adults with sickle cell disease. J Natl Black Nurses Assoc. 2001;12(2):36-43.
48. Harris A, Parker N, and Barker C. Adults with sickle cell disease: Psychological impact and experience of hospital services. Psychol. Health Med. 1998;3(2):171-179.
49. Butler DJ and Beltran LR. Functions of an adult sickle cell group: education, task orientation, and support. Health Soc Work. 1993;18(1):49-56.
50. Waters J and Thomas V. Pain from sickle-cell crisis. Nurs Times. 1995;91(16):29-31.
51. Labbe E, Herbert D, and Haynes J. Physicians' attitude and practices in sickle cell disease pain management. J Palliat Care. 2005;21 (4):246-251. (Pubitemid 43116685)
52. Witherspoon D and Drotar D. Correlates of adherence to prophylactic-penicillin therapy in children with sickle cell disease. Child Health Care. 2006;35(4):281-296. (Pubitemid 44893981)
53. Pejaver RK, Ahmed FE, and Al Hifzi I. Compliance to penicillin prophylaxis amongst Saudi children with sickle cell disease. J Ir Coll Phys Surg. 1997;26(4):268-270. (Pubitemid 27483852)
54. Mitchell MB, Lambright WD, Breish R et al. Meeting the challenge of managing vaso-occlusive crisis. J Healthc Qual. 2002;24 (3):4-8, 56.
55. Co JP, Johnson KB, Duggan AK, Casella JF, and Wilson M. Does a clinical pathway improve the quality of care for sickle cell anemia? Jt Comm J Qual Saf. 2003;29(4):181-190.
56. Jamison C and Brown HN. A special treatment program for patients with sickle cell crisis. Nurs Econ. 2002;20(3):126-132.
57. Cooper GS, Armitage KB, Ashar B et al. Design and implementation of an inpatient disease management program. Am J Manag Care. 2000;6(7):793-801. (Pubitemid 30623563)
58. Benjamin LJ, Swinson GI, and Nagel RL. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood. 2000;95(4):1130-1136.
59. Day J. An audit of pain management in acute sickle cell crisis. Nurs Times. 1997;93(2):33-34.
60. Brookoff D and Polomano R. Treating sickle cell pain like cancer pain. Ann Intern Med. 1992;116(5):364-368.
61. Fertleman CR, Gallagher A, and Rossiter MA. Evaluation of fast track admission policy for children with sickle cell crises: questionnaire survey of parents' preferences. BMJ. 1997;315(7109):650. (Pubitemid 27387176)
62. Treadwell MJ, Franck LS, and Vichinsky E. Using quality improvement strategies to enhance pediatric pain assessment. Int J Qual Health Care. 2002;14(1):39-47. (Pubitemid 34157062)
63. Treadwell MJ and Weissman L. Improving adherence with deferoxamine regimens for patients receiving chronic transfusion therapy. Semin Hematol. 2001;38(1 suppl 1)77-84. (Pubitemid 32110276)
64. Berkovitch M, Papadouris D, Shaw D, Onuaha N, Dias C, and Olivieri NF. Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell disease. Br J Clin Pharmacol. 1998;45(6):605-607. (Pubitemid 28270918)
65. Ketchen B, Hazzard A, Lassiter S et al. STARBRIGHT World: A pilot study of a home-based sickle cell psychoeducational intervention. Child Health Care. 2006;35(4):321-338. (Pubitemid 44893983)
66. Patik M, Phillips L, Kladny B, Captain A, Gettig E, and Krishnamurti L. Structured telephone-based outreach using nonmedical personnel can improve adherence to comprehensive care in families of children with sickle cell disease. Am J Hematol. 2006;81(6):462-464. (Pubitemid 43787937)
67. Beach MC, Price EG, Gary TL et al. Cultural competence: a systematic review of health care provider educational interventions. Med Care. 2005;43(4):356-373.
68. Lewin SA, Skea ZC, Entwistle V, Zwarenstein M, Dick J. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst Rev. 2001;(4):CD003267.■